documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

6 rows where docket_id = "FDA-2004-E-0199" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 4

document_type 3

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-E-0199-0006 FDA Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958 FDA-2004-E-0199 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Sidley Austin Brown and Wood LLP Rule Certificate Extending Patent Term 2007-04-20T04:00:00Z 2007 4     2025-11-07T02:01:58Z   0 0 0900006480470bc3
FDA-2004-E-0199-0005 FDA Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958 FDA-2004-E-0199 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-09-08T04:00:00Z 2006 9     2025-11-07T02:00:13Z   0 0 0900006480470bc2
FDA-2004-E-0199-0004 FDA Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958 FDA-2004-E-0199 Determination of Regulatory Review Period for Purposes of Patent Extension; XOLAIR Notice General Notice 2006-01-30T05:00:00Z 2006 1 2006-01-30T05:00:00Z   2025-11-07T01:58:08Z E6-1078 0 0 0900006480470bc0
FDA-2004-E-0199-0003 FDA Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958 FDA-2004-E-0199 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-01-11T05:00:00Z 2006 1     2025-11-07T01:55:07Z   0 0 0900006480470bbf
FDA-2004-E-0199-0002 FDA Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958 FDA-2004-E-0199 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2005-04-19T04:00:00Z 2005 4     2025-11-07T01:53:13Z   0 0 0900006480470bbe
FDA-2004-E-0199-0001 FDA Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958 FDA-2004-E-0199 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2004-01-14T05:00:00Z 2004 1     2025-11-07T01:51:22Z   0 0 0900006480470bb2

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);